Search images on Google Product Monograph
Active Ingredients:
- olopatadine hydrochloride, 665 MCG/ACT
- mometasone furoate (mometasone furoate monohydrate), 25 MCG/ACT
DIN: 02531186
Dosage Form(s): SPRAY, METERED DOSE
Route(s) of Administration: NASAL
Description: SUSPENSION
Schedule: Prescription
Company: GLENMARK SPECIALTY SA
ATC:
- R01 - NASAL PREPARATIONS (ATC, WHO, Wiki)
- R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE (ATC, WHO)
- R01AD - Corticosteroids (ATC, WHO)
- R01AD59 - MOMETASONE, COMBINATIONS (WHO)